LINC00355
gene geneOn this page
Summary
LINC00355 (long intergenic non-protein coding RNA 355, HGNC:27061) is a long non-coding RNA gene on chromosome 13q21.31.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27061 |
| Approved symbol | LINC00355 |
| Name | long intergenic non-protein coding RNA 355 |
| Location | 13q21.31 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000227674 |
| Ensembl biotype | lncRNA |
| Entrez | 144766 |
| RNAcentral | URS0000158102 — lncRNA, 1878 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000456627, ENST00000650541, ENST00000654282, ENST00000669788
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000456627 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001422653 | 63986371 | 63987039 |
| ENSE00001637192 | 64003348 | 64003465 |
| ENSE00001639317 | 64002385 | 64002409 |
| ENSE00001685608 | 63990096 | 63990200 |
| ENSE00001723759 | 64075242 | 64076011 |
| ENSE00001761432 | 64034347 | 64034537 |
Expression profiles
Bgee: expression breadth broad, 92 present calls, max score 71.40.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3566 / max 23.9546, expressed in 126 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 137484 | 0.2197 | 102 |
| 137485 | 0.1370 | 71 |
Top tissues by expression
192 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 71.40 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 63.00 | gold quality |
| cortical plate | UBERON:0005343 | 59.53 | gold quality |
| ganglionic eminence | UBERON:0004023 | 58.72 | gold quality |
| monocyte | CL:0000576 | 54.53 | gold quality |
| cortex of kidney | UBERON:0001225 | 53.60 | gold quality |
| medial globus pallidus | UBERON:0002477 | 53.08 | gold quality |
| globus pallidus | UBERON:0001875 | 50.26 | gold quality |
| prefrontal cortex | UBERON:0000451 | 49.30 | silver quality |
| blood | UBERON:0000178 | 49.12 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.49 | silver quality |
| muscle of leg | UBERON:0001383 | 47.12 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 46.76 | gold quality |
| gastrocnemius | UBERON:0001388 | 46.52 | silver quality |
| ectocervix | UBERON:0012249 | 46.23 | gold quality |
| cerebellar cortex | UBERON:0002129 | 46.16 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 46.04 | silver quality |
| deltoid | UBERON:0001476 | 46.03 | gold quality |
| cerebellum | UBERON:0002037 | 45.50 | silver quality |
| vermiform appendix | UBERON:0001154 | 45.17 | silver quality |
| islet of Langerhans | UBERON:0000006 | 44.84 | silver quality |
| heart left ventricle | UBERON:0002084 | 44.59 | gold quality |
| pancreas | UBERON:0001264 | 44.55 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 44.42 | silver quality |
| cardiac ventricle | UBERON:0002082 | 44.19 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 43.64 | silver quality |
| frontal cortex | UBERON:0001870 | 43.63 | silver quality |
| neocortex | UBERON:0001950 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| tibial artery | UBERON:0007610 | 43.31 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.78 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 11)
- A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1. (PMID:31689506)
- Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion. (PMID:31749189)
- LINC00355 inhibits apoptosis and promotes proliferation of gastric cancer cells by regulating Wnt/beta-catenin signaling pathway. (PMID:32894544)
- LINC00355 promoted the progression of lung squamous cell carcinoma through regulating the miR-466/LYAR axis. (PMID:33111744)
- Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis. (PMID:33720323)
- Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis. (PMID:33882126)
- LINC_00355 promotes gastric cancer progression by upregulating PHF19 expression through sponging miR-15a-5p. (PMID:34078310)
- lncRNA LINC00355 Acts as a Novel Biomarker and Promotes Glioma Biological Activities via the Regulation of miR-1225/FNDC3B. (PMID:34603558)
- LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis. (PMID:34641698)
- Exosomal LINC00355 promotes the malignant progression of gastric cancer through histone deacetylase HDAC3-mediated TP53INP1 transcriptional inhibition. (PMID:36640904)
- LINC00355 Mediates CTNNBIP1 Promoter Methylation and Promotes Endoplasmic Reticulum Stress-Induced Podocyte Injury in Diabetic Nephropathy. (PMID:36738224)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.